Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTBP2 | P56545 | 1/20 | 0.66 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.58 |
| ▸ | HTR3B | O95264 | 1/20 | 0.58 |
| ▸ | HTR3A | P46098 | 1/20 | 0.58 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.58 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.58 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.58 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | PNMT | P11086 | 1/20 | 0.52 |
| ▸ | RXRA | P19793 | 1/20 | 0.50 |
| ▸ | RXRB | P28702 | 1/20 | 0.50 |
| ▸ | RXRG | P48443 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL5702482 | 0.98 | CTBP2 (0.64) | CTBP2HTR3EHTR3BHTR3AHTR3D | |
| Ammonia Solution, Strong SCHEMBL28761900 | 0.98 | CTBP2 (0.64) | CTBP2HTR3EHTR3BHTR3AHTR3D | |
| Hydrochloric Acid SCHEMBL2531827 | 0.98 | CTBP2 (0.64) | CTBP2HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL11774837 | 0.93 | CTBP2 (0.58) | CTBP2HTR3EHTR3BHTR3AHTR3D | |
| Parachlorophenol SCHEMBL9108351 | 0.89 | CTBP2 (0.55) | CTBP2HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL4208044 | 0.89 | GRIN2D (0.55) | CTBP2AKR1B1CA2LMNA | |
| 3-Chloroaniline SCHEMBL11667901 | 0.86 | ALDH1A1 (0.57) | CTBP2HTR3EHTR3BHTR3AHTR3D | |
| P-Cresol SCHEMBL9107906 | 0.85 | CTBP2 (0.51) | CTBP2HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL11172110 | 0.85 | CTBP2 (0.62) | CTBP2HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL27834585 | 0.85 | CTBP2 (0.58) | CTBP2HTR3EHTR3BHTR3AHTR3D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1694 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025057535-A1 | SEPARATION MEMBRANE | 日東電工株式会社 | 2025-03-20 | — | — | WO | claimed |
| CN-113200934-B | Compound containing benzomorpholone-biphenyl skeleton and preparation method and application thereof | 郑州大学 | 2022-05-31 | — | — | CN | claimed |
| CN-114478122-A | Novel functional fertilizer synergist and application | 郑州郑氏化工产品有限公司 | 2022-05-13 | — | — | CN | claimed |
| CN-114106943-A | Multienzyme cleaning agent and processing equipment thereof | 山东消博士消毒科技股份有限公司 | 2022-03-01 | — | — | CN | claimed |
| CN-113930293-A | Rapid and efficient multienzyme cleaning agent and preparation method thereof | 山东消博士消毒科技股份有限公司 | 2022-01-14 | — | — | CN | claimed |
| US-11124472-B2 | Myocardial regeneration promoting compounds, preparation method thereof, and pharmaceutical composition | GENHEALTH PHARMA CO., LTD. (TW) | 2021-09-21 | — | — | US | claimed |
| CN-113200934-A | Compound containing benzomorpholone-biphenyl skeleton and preparation method and application thereof | 郑州大学 | 2021-08-03 | — | — | CN | claimed |
| EP-3725763-A1 | MYOCARDIAL REGENERATION PROMOTING COMPOUNDS, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION, AND THEIR USE | Genhealth Pharma Co., Ltd. (TW) | 2020-10-21 | — | — | EP | claimed |
| US-20200317602-A1 | MYOCARDIAL REGENERATION PROMOTING COMPOUNDS, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION, AND THEIR USE | GENHEALTH PHARMA CO., LTD. (TW) | 2020-10-08 | — | — | US | claimed |
| CN-107417509-B | Preparation method of phenylacetic acid compound | 上海康鹏科技股份有限公司 | 2020-08-25 | — | — | CN | claimed |
| US-5605930-A | ADMINISTERING PHENYLACETIC ACID AS AN INHIBITOR OF THE MEVALONATE PATHWAY | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-02-25 | — | — | US | claimed |
| EP-0465358-B1 | 2-Thienylglycidic acid derivative, process for its preparation and its use as synthetic intermediate | SANOFI SA (FR) | 1996-02-07 | — | — | EP | claimed |
| EP-0281459-B1 | Dextrorotatory enantiomer of alpha-(4,5,6,7-tetrahydrothieno[3,2-c]pyrid-5-yl)(2-chlorophenyl)methyl acetate, process for its preparation and pharmaceutical compositions containing it | SANOFI SA (FR) | 1995-04-26 | — | — | EP | claimed |
| EP-0465358-A1 | 2-Thienylglycidic acid derivative, process for its preparation and its use as synthetic intermediate | SANOFI (FR) | 1992-01-08 | — | — | EP | claimed |
| EP-0281459-A1 | Dextrorotatory enantiomer of alpha-(4,5,6,7-tetrahydrothieno[3,2-c]pyrid-5-yl)(2-chlorophenyl)methyl acetate, process for its preparation and pharmaceutical compositions containing it | SANOFI (FR) | 1988-09-07 | — | — | EP | claimed |
| EP-0192535-A1 | Alpha-[oxo-2-hexahydro-2,4,5,6,7a-thieno(3,2-c)pyridyl-5]phenyl-acetic-acid derivatives, process for their preparation and their therapeutical use | SANOFI (FR) | 1986-08-27 | — | — | EP | claimed |
| EP-0021178-B1 | MAYTANSINOIDS, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1984-01-18 | — | — | EP | claimed |
| US-4390723-A | BIS(8-QUINOLINOLATE) COPPER COMPLEX CATALYST | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 1983-06-28 | — | — | US | claimed |
| US-4317821-A | ANTITUMOR AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1982-03-02 | — | — | US | claimed |
| EP-0021178-A1 | Maytansinoids, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1981-01-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200317602-A1 | MYOCARDIAL REGENERATION PROMOTING COMPOUNDS, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION, AND THEIR USE | TNNI3, TNNT2, MYLK2 | CTBP2 2175/4885HTR3E 1448/4885HTR3B 1486/4885 |
| US-11124472-B2 | Myocardial regeneration promoting compounds, preparation method thereof, and pharmaceutical composition | TNNI3, MYLK2, TNNT2 | CTBP2 2136/4885HTR3E 1292/4885HTR3B 1246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.